CATEGORIES

Press Release

LATEST

TRENDING

EDITORS CHOICE

New Data Shows No Evidence of COVID-19 Spread in Gyms

Of More than 49.4 Million Health Club Visits, Only 0.0023 Percent Tested Positive for COVID-19

NLR. Millions at Risk from Leprosy. Study Reveals Figures

To interrupt leprosy transmission and reduce annual new cases significantly, preventive treatment needs to be implemented in all leprosy-endemic countries

INOVIO’s COVID-19 Vaccine Shows Durable Antibody and T Cell Responses

INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 Virus

FDA approves Ready-to-Use Ephedrine Injection, Emerphed™

Nexus Pharmaceuticals, Inc. Announces Approval of Emerphed™ (ephedrine sulfate) Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial)